Ditchcarbon
  • Contact
  1. Organizations
  2. Agena Bioscience, Inc.
Public Profile
Research Services
US
updated 23 days ago

Agena Bioscience, Inc. Sustainability Profile

Company website

Agena Bioscience, Inc., headquartered in the United States, is a leading player in the biotechnology industry, specialising in innovative genomic solutions. Founded in 2006, the company has made significant strides in the development of its proprietary MassARRAY® technology, which enables precise and cost-effective genetic analysis. With a focus on applications in clinical research, oncology, and inherited disease testing, Agena's core products, including the MassARRAY System and a range of assay panels, stand out for their high throughput and flexibility. The company has established a strong market position, recognised for its commitment to advancing personalised medicine and improving patient outcomes. Through continuous innovation and strategic partnerships, Agena Bioscience remains at the forefront of genomic technology, serving a global clientele across major operational regions.

DitchCarbon Score

How does Agena Bioscience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

36

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Agena Bioscience, Inc.'s score of 36 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

Agena Bioscience, Inc.'s reported carbon emissions

Inherited from Mesa Laboratories, Inc.

Agena Bioscience, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Mesa Laboratories, Inc., which may influence its climate commitments and reporting practices. While there are no documented reduction targets or specific climate pledges from Agena Bioscience, it is important to note that emissions data and climate initiatives may be inherited from its parent company, Mesa Laboratories, Inc. This relationship suggests that any climate strategies or performance metrics may align with those of Mesa Laboratories, although specific details are not provided. As a part of the broader industry context, companies like Agena Bioscience are increasingly expected to adopt transparent climate commitments and set measurable reduction targets in line with global sustainability goals. However, without specific data or commitments available, it is challenging to assess their current climate impact or future initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
389,800
000,000
Scope 2
1,186,230
0,000,000
Scope 3
-
-

How Carbon Intensive is Agena Bioscience, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Agena Bioscience, Inc.'s primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Agena Bioscience, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Agena Bioscience, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Agena Bioscience, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Agena Bioscience, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Agena Bioscience, Inc.'s Emissions with Industry Peers

10x Genomics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Nanostring Technologies

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Cytek Biosciences, Inc.

US
•
Research and development services (73)
Updated 28 days ago

Akoya Biosciences, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 2 months ago

Foundation Medicine, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Guardant Health

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy